Avidity Partners 13F holdings, Q4 2020
Holdings as of December 31, 2020 · filings on SEC EDGAR · latest filing →
Avidity Partners disclosed 94 US equity positions worth $3.0bn in its Q4 2020 13F filing. The largest position was AVTR at 6.2% of the reported book, followed by ARVN and ABBV. Against the Q3 2020 filing, it opened 25 new positions, added to 21 and reduced 4 among the top 50 holdings.
What did Avidity Partners own in Q4 2020? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2020 |
|---|---|---|---|---|---|---|---|
| 1 | AVTR AVANTOR INC | Healthcare | 6.2% | $184.9m | 6,566,700 | 44% | added |
| 2 | ARVN ARVINAS INC | Healthcare | 5.1% | $151.8m | 1,787,358 | 33% | added |
| 3 | ABBV ABBVIE INC | Healthcare | 4.9% | $145.3m | 1,356,000 | -11% | reduced |
| 4 | LLY LILLY ELI & CO | Healthcare | 4.6% | $136.8m | 810,500 | – | new |
| 5 | AZN ASTRAZENECA PLC | Healthcare | 3.9% | $115.0m | 2,300,000 | – | new |
| 6 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 3.2% | $96.7m | 3,445,772 | – | new |
| 7 | DGX QUEST DIAGNOSTIC INC | Healthcare | 3.2% | $94.4m | 792,100 | 97% | added |
| 8 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 2.9% | $87.1m | 992,900 | – | new |
| 9 | HORIZON THERAPEUTICS PUB L | 2.9% | $85.5m | 1,169,300 | 26% | added | |
| 10 | MIRATI THERAPEUTICS INC | 2.8% | $83.5m | 380,000 | 38% | added | |
| 11 | NBP I MAB | Healthcare | 2.5% | $75.0m | 1,591,000 | 19% | added |
| 12 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.5% | $73.6m | 3,308,000 | 78% | added |
| 13 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 2.0% | $59.0m | 1,135,000 | 26% | added |
| 14 | CHANGE HEALTHCARE INC | 1.9% | $57.5m | 3,082,100 | 22% | added | |
| 15 | STTK SHATTUCK LABS INC | Healthcare | 1.7% | $49.2m | 938,813 | – | new |
| 16 | NTRA NATERA INC | Healthcare | 1.6% | $47.8m | 479,800 | -5% | reduced |
| 17 | ARENA PHARMACEUTICALS INC | 1.6% | $47.7m | 621,000 | – | new | |
| 18 | CHEMOCENTRYX INC | 1.6% | $46.9m | 757,000 | – | new | |
| 19 | TRILLIUM THERAPEUTICS INC | 1.6% | $46.9m | 3,185,200 | 82% | added | |
| 20 | APELLIS PHARMACEUTICALS INC | 1.5% | $44.3m | 774,000 | 24% | added | |
| 21 | CAH CARDINAL HEALTH INC | Healthcare | 1.5% | $43.3m | 808,000 | – | new |
| 22 | BIOHAVEN PHARMACTL HLDG CO L | 1.4% | $42.2m | 491,800 | -62% | reduced | |
| 23 | ORGO ORGANOGENESIS HLDGS INC | Healthcare | 1.4% | $41.6m | 5,521,500 | – | new |
| 24 | BHC BAUSCH HEALTH COS INC | Healthcare | 1.4% | $41.0m | 1,972,000 | – | new |
| 25 | KDMN KADMON HLDGS INC | 1.3% | $39.7m | 9,570,000 | 6% | added | |
| 26 | XLRN ACCELERON PHARMA INC | 1.3% | $38.3m | 299,000 | – | new | |
| 27 | SRPT SAREPTA TEHRAPEUTICS INC | Healthcare | 1.2% | $37.1m | 217,400 | – | new |
| 28 | ATHIRA PHARMA INC | 1.2% | $35.8m | 1,043,873 | 2% | added | |
| 29 | MDT MEDTRONIC PLC | Healthcare | 1.2% | $35.3m | 301,000 | 66% | added |
| 30 | CATALENT INC | 1.2% | $35.1m | 337,000 | 6% | added | |
| 31 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 1.2% | $34.8m | 147,300 | – | new |
| 32 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 1.1% | $33.1m | 731,000 | 21% | added |
| 33 | SIGILON THERAPEUTICS INC | 1.1% | $33.0m | 688,000 | – | new | |
| 34 | EXK EXACT SCIENCES CORP | Basic Materials | 1.1% | $32.7m | 247,000 | – | new |
| 35 | ESSA PHARMA INC | 1.0% | $30.5m | 2,558,000 | 23% | added | |
| 36 | CRDF CARDIFF ONCOLOGY INC | 1.0% | $28.9m | 1,607,000 | – | new | |
| 37 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.0% | $28.8m | 300,000 | – | new |
| 38 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.9% | $28.2m | 527,600 | – | new |
| 39 | AUPH AURINIA PHARMACEUTICALS INC | Healthcare | 0.9% | $27.7m | 2,000,000 | -44% | reduced |
| 40 | ZYME ZYMEWORKS INC | Healthcare | 0.9% | $27.3m | 578,100 | 136% | added |
| 41 | 2655787D BLUEPRINT MEDICINES CORP | 0.9% | $26.9m | 240,000 | – | new | |
| 42 | ATEC ALPHATEC HLDGS INC | Healthcare | 0.9% | $26.9m | 1,850,873 | – | new |
| 43 | BTAI BIOXCEL THERAPEUTICS INC | 0.8% | $25.3m | 547,000 | 2% | added | |
| 44 | ATRC ATRICURE INC | Healthcare | 0.8% | $24.9m | 446,600 | – | new |
| 45 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 0.8% | $24.8m | 1,239,000 | 24% | added |
| 46 | SHC SOTERA HEALTH CO | Healthcare | 0.6% | $19.2m | 700,000 | – | new |
| 47 | CRIS CURIS INC | Healthcare | 0.6% | $19.2m | 2,342,100 | – | new |
| 48 | SIBN SI BONE INC | Healthcare | 0.6% | $19.1m | 639,884 | – | new |
| 49 | DVAX DYNAVAX TECHNOLOGIES CORP | 0.6% | $17.8m | 4,000,000 | 98% | added | |
| 50 | BELLUS HEALTH INC NEW | 0.6% | $17.5m | 5,726,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.